Skip to main content
Journal cover image

Aldafermin reduces hydrophobic bile acids in a 24-week, randomized, double-blind, placebo-controlled, multicenter study in patients with non-alcoholic steatohepatitis

Publication ,  Conference
Sanyal, A; Ling, L; Neff, G; Guy, C; Bashir, M; Paredes, A; Frias, J; Younes, ZH; Trotter, JF; Gunn, NT; Moussa, S; Kohli, A; Nelson, K ...
Published in: JOURNAL OF HEPATOLOGY
2021

Duke Scholars

Published In

JOURNAL OF HEPATOLOGY

EISSN

1600-0641

ISSN

0168-8278

Publication Date

2021

Volume

75

Start / End Page

S616 / S617

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sanyal, A., Ling, L., Neff, G., Guy, C., Bashir, M., Paredes, A., … Harrison, S. (2021). Aldafermin reduces hydrophobic bile acids in a 24-week, randomized, double-blind, placebo-controlled, multicenter study in patients with non-alcoholic steatohepatitis. In JOURNAL OF HEPATOLOGY (Vol. 75, pp. S616–S617).
Journal cover image

Published In

JOURNAL OF HEPATOLOGY

EISSN

1600-0641

ISSN

0168-8278

Publication Date

2021

Volume

75

Start / End Page

S616 / S617

Related Subject Headings

  • Gastroenterology & Hepatology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences